EUVIMEDOpdag EUVIMED
Video/Audio

Performing an In Vitro Genome-Wide CRISPR Knockout Screen in Chimeric Antigen Receptor T Cells

Carli Stewart, Claudia Manriquez Roman, Saad S Kenderian

Journal of Visualized Experiments · 2025

DOI: 10.3791/67338 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2025. Written by Carli Stewart and 2 co-authors. Institution: T Cell Engineering, Mayo Clinic; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic; Department of Molecular Pharmacology and Experiment…. Major MEDLINE topics: Receptors, Chimeric Antigen, Gene Knockout Techniques, CRISPR-Cas Systems, T-Lymphocytes. 38 references. Funded by: NCI NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Chimeric antigen receptor T (CART) cell therapy is an innovative form of targeted immunotherapy that has revolutionized the treatment of cancer. However, the durable response remains limited. Recent studies have shown that the epigenetic landscape of preinfusion CART cell products can influence response to therapy, and gene editing has been proposed as a solution. However, more work needs to be done to determine the optimal gene editing strategy. Genome-wide CRISPR screens have become popular tools to both investigate mechanisms of resistance and optimize gene editing strategies. Yet their application to primary cells presents many challenges. Here we describe a method to complete a genome-wide CRISPR knockout screen in CART cells from healthy donors. As a proof-of-concept model, we designed this method to investigate the development of exhaustion in CART cells targeting the CD19 antigen. However, we believe that this approach can be used to address a variety of mechanisms of resistance to therapy in different CAR constructs and tumor models.

Subjects

MeSH terms (MEDLINE)

Receptors, Chimeric AntigenGene Knockout TechniquesCRISPR-Cas SystemsT-LymphocytesHumansAntigens, CD19Immunotherapy, AdoptiveGene EditingClustered Regularly Interspaced Short Palindromic Repeats

Substances

Receptors, Chimeric AntigenAntigens, CD19

Authors and institutions

  • T Cell Engineering, Mayo Clinic; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic.
  • T Cell Engineering, Mayo Clinic; Center for Regenerative Biotherapeutics, Mayo Clinic.
  • T Cell Engineering, Mayo Clinic; Division of Hematology, Mayo Clinic; Department of Immunology, Mayo Clinic; Kenderian.Saad@mayo.edu.

Funding

  • NCI NIH HHS

Cite

APA

Stewart, C., Manriquez Roman, C., & Kenderian, S. S. (2025). Performing an In Vitro Genome-Wide CRISPR Knockout Screen in Chimeric Antigen Receptor T Cells. Journal of Visualized Experiments. https://doi.org/10.3791/67338

Vancouver

Stewart C, Manriquez Roman C, Kenderian SS. Performing an In Vitro Genome-Wide CRISPR Knockout Screen in Chimeric Antigen Receptor T Cells. Journal of Visualized Experiments. 2025. doi:10.3791/67338

BibTeX
@article{Stewart2025,
  author = {Stewart, Carli and Manriquez Roman, Claudia and Kenderian, Saad S},
  title = {Performing an In Vitro Genome-Wide CRISPR Knockout Screen in Chimeric Antigen Receptor T Cells},
  journal = {Journal of Visualized Experiments},
  year = {2025},
  doi = {10.3791/67338}
}
Start for free →